PROM1 and glioma: Similarly, CD133 (PROM1), a stem cell marker found particularly enriched in pseudopalisades surrounding necrosis, correlates with tumor growth, therapy resistance, and recurrence in GBM stem cells, with high levels observed in EVs from both melanoma and glioma [32,66].